comparemela.com

Phasei Dose Escalation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NKGen Biotech Announces Poster Presentation at the 16th Annual Clinical Trials on Alzheimer s disease Conference

SANTA ANA - NKGen Biotech Inc. , a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell.

United statesCesar alejandro amescuaBlanca isaura acosta galloClemente humberto zuniga gilLucia huiJuan mataThank leeDenise chuaSean hongKatia betitoRufino menchaca diazPauly changExchange commissionNkgen biotech incClinical trialsDisease annual meeting

NKGen Biotech Announces Poster Presentation at the 16th Annual Clinical Trials on Alzheimer s Disease (CTAD) Conference -October 19, 2023 at 08:01 am EDT

SANTA ANA, Calif., Oct. 19, 2023 NKGen Biotech Inc. , a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK.

United statesThank leeBlanca isaura acosta galloKevin gardnerClemente humberto zuniga gilSean hongDenise chuaRufino menchaca diazChris calabresePauly changKatia betitoLucia huiCesar alejandro amescuaJuan mataExchange commissionNkgen biotech inc

Zai Lab to Highlight New Data from its Oncology Portfolio at 2023 AACR Annual Meeting

New translational and clinical biomarker data from Zai Lab’s global oncology program ZL-1211 will be featured in a poster presentation SHANGHAI and CAMBRIDGE, Mass., April 11, 2023 Zai Lab. | April 11, 2023

United kingdomUnited statesRafael amadoJennifer chang xiaoyu chenHead of global oncology researchZai labZai lab forwardExchange commissionAmerican association for cancer researchZai lab limitedLab limitedCancer researchAnnual meetingGlobal oncology researchClinical translationAdvanced solid tumors

vimarsana © 2020. All Rights Reserved.